Analysis of dental biomaterials market drivers, key opportunity

Dental biomaterials are resin-based materials such as ceramic and metallic used to replace damaged teeth, jawbones, or teeth. They typically have a high rate of success in oral treatment and prevention. They fill cavities while also promoting healing. Metals, polymers, ceramics, and composite structures are biocompatible synthetic dental materials, whereas natural tissues include enamel, dentin, bone, cementum, and other intraoral tissues.

The global dental biomaterials market was worth $7.70 billion in 2021 and is expected to be worth $14.5 billion by 2030, representing a CAGR of 7.29% from 2021 to 2030.

An increase in dental disorders, an increase in dental tourism, the penetration of dental implants, and an increase in people’s income are the factors driving the global dental biomaterials market growth.

Key industry drivers

Increase in incidence of dental disorders

The primary factor boosting the Dental Biomaterials Market is the rising prevalence of oral disorders. The rising incidence of oral disorders such as periodontal disease, oral cancer, tooth decay, halitosis, and dental caries, among others, is accelerating market growth. Patients with oral disorders are undergoing a wide range of elective procedures for treatment, which is increasing demand for dental biomaterials, which are promising products with a high success rate in oral treatment and prevention. Over the forecast period, this factor is expect to drive the global dental biomaterials market.

According to the center for disease control and prevention, signs of gum disease are present in 46% of all adults age 30 and older, with severe gum disease affecting approximately 9% of adults. Untreated tooth decay affects approximately 26% of adults in the United States.

Growing geriatric population

The geriatric population suffering from oral diseases such as oral cancer, gum disease, tooth decay, and so on is a major driver of market growth. According to the US Census, by 2060, the number of US adults aged 65 and up is estimated to reach 98 million, accounting for 24 percent of the total population. According to the Centers for Disease Control and Prevention, nearly two-thirds of adults aged 65 and older, or nearly 68 percent of the elderly population, have gum disease and oral cancers, which are diagnosed at the age of 62 years.

Increased awareness and disposable income

Increased awareness of the significance of dental implants in middle and low-income countries will drive market growth during the forecast period. Additionally, with the increased disposable income in developed countries, demand for aesthetic treatments like gum contouring and teeth whitening has also increased. This trend is expect to drive market growth for the remainder of the forecast period.

Key Opportunity

In recent years, various government bodies contributed to the market research and development by making significant investments in advanced dental biomaterials such as Nanoparticulate hydroxyapatite for bone therapy applications and using nanoparticles as biomaterials in biomaterials dentistry, which is expect to create a wide range of growth opportunities for the market.

Segmentation analysis

The metallic biomaterials segment held a dominant position in 2021 on the basis of product type.
The increasing use of dentisy implants, the high strength of materials, and the widespread use of metallic biomaterials
In dentistry are the factors attribute to the growth of this market segment.
On the basis of application, in 2021, the orthodontics segment accounted for the largest market share of 43%. Due to the rise in dental conditions and tooth decays, there is a growing need for dental biomaterials in orthodontics. Additionally, rising disposable income and the trend toward medical tourism are propelling this market’s expansion globally.
On the basis of end-user, in 2021, the dental laboratories segment recorded a maximum share of 38%.
The growing consumer awareness related to oral hygiene and health, growing dental disorders and infections, growing demand for dental surgeries. And implants are the factors stimulating the growth of this segment.
In 2021, North America held a 37% revenue share in the dental biomaterials market.
The growth in product launches with government support, an increase in the burden of dental disorders.
The presence of a sizable geriatric population is the key driver behind the market’s development.
More than 5 million Americans aged 65 or above have lost their teeth, including about 3 million who are edentulous.